Find clinical trials for Melanoma in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Melanoma trials near New York, NY, USA:
of DYP688 as a single agent in patients with metastatic uveal melanoma (MUM) and other melanomas harboring GNAQ/11 mutations....
Phase 1, Phase 2
New York, New York, United States and 10 other locations
Neoadjuvant/adjuvant IDE196 (darovasertib) in patients with primary uveal melanoma...
Phase 2
Manhasset, New York, United States and 22 other locations
This is an open label study evaluating lifileucel (LN-144) in patients with metastatic uveal melanoma....
Phase 1
New York, New York, United States and 1 other location
ATLAS-IT-05 is an open-label, single-arm study in patients with advanced melanoma accessible for injections (cutaneous, subcutaneous, lymph ...
Phase 2
New York, New York, United States and 9 other locations
This study observes the antitumor activity, safety, tolerability, PK, and pharmacodynamics in patients with inoperable and/or metastatic melanoma...
Phase 2
New York, New York, United States and 40 other locations
therapy per local standard of care (SoC), best supportive care (BSC)) on protocol survivor follow up) in patients with advanced non-ocular melanoma...
Phase 2, Phase 3
New York, New York, United States and 70 other locations
safety, tolerability, and preliminary efficacy of belzupacap sarotalocan for the treatment of primary indeterminate lesions and small choroidal melanoma...
Phase 2
New York, New York, United States and 21 other locations
This is an open label study evaluating lifileucel (LN-144) in patients with melanoma brain metastases....
Phase 1
New York, New York, United States
of ANV419 with anti-PD1 antibody or with anti-CTLA4 antibody in adult participants with advanced (unresectable or metastatic) cutaneous melanoma...
Phase 1, Phase 2
Morristown, New York, United States of America and 24 other locations
Approximately 40 participants with locally advanced or metastatic melanoma will be enrolled in 20 sites in the United States into 1 of the f...
Phase 2
New York, New York, United States and 12 other locations
Clinical trials
Research sites
Resources
Legal